SCHEMBL16018458

SCHEMBL16018458

Cc1ccc(C(c2ccc(O)cc2)c2ccccc2C(=O)O)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.84
KMT2A Q03164 2/20 0.84
TDP1 Q9NUW8 2/20 0.84
GAA P10253 1/20 0.84
AKR1C3 P42330 1/20 0.46
MAPT P10636 2/20 0.43
ACHE P22303 1/20 0.41
LMNA P02545 2/20 0.40
IDE P14735 1/20 0.40
ALOX15 P16050 1/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
HMGB1 P09429 1/20 0.39
CA4 P22748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18568766 0.94 ALDH1A1 (0.72) ALDH1A1KMT2ATDP1GAAAKR1C3
SCHEMBL29636490 0.92 ALDH1A1 (1.00) ALDH1A1KMT2ATDP1GAAAKR1C3
SCHEMBL438546 0.92 ALDH1A1 (1.00) ALDH1A1KMT2ATDP1GAAAKR1C3
SCHEMBL1507640 0.90 ALDH1A1 (0.96) ALDH1A1KMT2ATDP1GAAAKR1C3
Phenol SCHEMBL1068767 0.90 ALDH1A1 (0.96) ALDH1A1KMT2ATDP1GAAMAPT
SCHEMBL8945914 0.81 ALDH1A1 (0.79) ALDH1A1KMT2ATDP1GAAAKR1C3
SCHEMBL13172304 0.78 ALDH1A1 (0.69) ALDH1A1KMT2ATDP1GAAMAPT
SCHEMBL29664246 0.77 ALDH1A1 (0.62) ALDH1A1KMT2ATDP1GAAMAPT
Salicylic Acid SCHEMBL27937535 0.76 ALDH1A1 (0.69) ALDH1A1KMT2ATDP1GAAAKR1C3
SCHEMBL10031846 0.76 TDP1 (0.66) ALDH1A1KMT2ATDP1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9696623-B2 Photosensitive compositions and applications thereof PROMERUS, LLC (US) 2017-07-04 US disclosed
US-20160223908-A1 PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF PROMERUS, LLC (US) 2016-08-04 US disclosed
US-9341949-B2 Photosensitive compositions and applications thereof PROMERUS, LLC (US) 2016-05-17 US disclosed
US-9096607-B2 Tumor necrosis factor inhibitors THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-08-04 US disclosed
US-20140322647-A1 PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF SUMITOMO BAKELITE CO., LTD (JP) 2014-10-30 US disclosed
US-20140256803-A1 TUMOR NECROSIS FACTOR INHIBITORS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256803-A1 TUMOR NECROSIS FACTOR INHIBITORS TNFRSF1A, TNF, TNFRSF9 ALDH1A1 3912/4885KMT2A 4709/4885TDP1 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.